Mizuho Maintains Neutral on Incyte, Lowers Price Target to $77
Portfolio Pulse from Benzinga Newsdesk
Mizuho analyst Mara Goldstein has maintained a Neutral rating on Incyte (NASDAQ:INCY) and reduced the price target from $82 to $77.

December 14, 2023 | 5:55 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Mizuho analyst Mara Goldstein maintains a Neutral stance on Incyte but lowers the price target from $82 to $77.
The reduction in price target by Mizuho suggests a less optimistic outlook on Incyte's stock value, which could lead to a negative short-term impact on the stock price. The Neutral rating indicates that the analyst does not see significant upside or downside potential, but the lowered target price may influence investor sentiment negatively.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100